| aSAH | Aneurysmal Subarachnoid Hemorrhage |
| IA | Intracranial Aneurysm |
| DCI | Delayed Cerebral Ischemia |
| CTLA-4 | Cytotoxic T-lymphocyte Antigen-4 |
| PD-L1 | Programmed Death-Ligand 1 |
| sCTLA-4 | Soluble Cytotoxic T-lymphocyte Antigen-4 |
| sPD-L1 | Soluble Programmed Death-Ligand 1 |
| mPD-L1 | Membrane-bound Programmed Death-Ligand 1 |
| exoPD-L1 | Exosomal Programmed Death-Ligand 1 |
| MMP | Matrix Metalloproteinase |
| TLR | Toll-like Receptor |
| DAMP | Damage-Associated Molecular Pattern |
| SIRS | Systemic Inflammatory Response Syndrome |
| Treg | Regulatory T Cell |
| Th17 | T-helper 17 Cell |
| WFNS | World Federation of Neurological Societies |
| mRS | Modified Rankin Scale |
| CTA | Computed Tomography Angiography |
| DSA | Digital Subtraction Angiography |
| AVM | Arteriovenous Malformation |
| CRP | C-Reactive Protein |
| SD | Standard Deviation |
| IQR | Interquartile Range |
| NSCLC | Non-Small Cell Lung Cancer |
| CNS | Central Nervous System |
| ROS | Reactive Oxygen Species |
| HLA-DR | Human Leukocyte Antigen-DR isotype |